gold has been researched along with Soft Tissue Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albertini, M; Gan, J; Hank, J; Heisey, D; Larson, M; Mahvi, DM; Pharo, L; Schalch, H; Schiller, J; Shi, FS; Sondel, PM; Warner, T; Weber, S; Yang, NS | 1 |
Grimelius, L; Olsson, Y | 1 |
Herter, P; Homann, H; Krause, L; Kuhnen, C; Muehlberger, T; Müller, KM; Müller, O; Steinau, HU | 1 |
1 trial(s) available for gold and Soft Tissue Neoplasms
Article | Year |
---|---|
Immunization by particle-mediated transfer of the granulocyte-macrophage colony-stimulating factor gene into autologous tumor cells in melanoma or sarcoma patients: report of a phase I/IB study.
Topics: Biolistics; Cancer Vaccines; DNA, Complementary; Dose-Response Relationship, Immunologic; Feasibility Studies; Gold; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypersensitivity, Delayed; Immunologic Factors; Injections, Intradermal; Leiomyosarcoma; Liposarcoma; Melanoma; Safety; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Tumor Cells, Cultured; Vaccines, DNA | 2002 |
2 other study(ies) available for gold and Soft Tissue Neoplasms
Article | Year |
---|---|
A silver-gold impregnation technique for demonstration of striated muscle elements.
Topics: Gold; Humans; Muscles; Rhabdomyosarcoma; Silver; Soft Tissue Neoplasms; Staining and Labeling | 1980 |
Beta-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Nuclear; Base Sequence; beta Catenin; Cell Division; Cell Nucleus; Cytoskeletal Proteins; Cytosol; DNA Mutational Analysis; Female; Fluorescent Antibody Technique, Indirect; Gold; Humans; Ki-67 Antigen; Male; Microscopy, Immunoelectron; Middle Aged; Molecular Sequence Data; Neoplasm Staging; Nuclear Proteins; Prognosis; Sarcoma; Soft Tissue Neoplasms; Staining and Labeling; Trans-Activators | 2000 |